Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

Schizophrenia Clinical Trial

Official title:

Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01611337
• Other study ID #: 2012-A00155-38
• Status: Completed
• Phase: N/A
• First received: May 29, 2012
• Last updated: September 18, 2017
• Start date: June 2012
• Est. completion date: July 2017

Study information

• Verified date: September 2017
• Source: Centre Hospitalier Esquirol
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Therapeutic alliance, and drug observance are major difficulties in the care of persons presenting schizophrenic symptomatology. They appear to be linked to insight, the consciousness that one has of his troubles. Nurse care in psychiatry aims at improving it, but usually without using specific evaluation tool. Insight is usually not evaluated during care, and its evolution is also not known, although it is highly probable that a positive evolution of insight for a person in hospital correlated to an adapted and optimal care by the medical and nursing teams. The investigators do not know examples of insight evaluation during a sequence of hospital care, or any evidence of insight variation in relation to evolution abilities of some schizophrenic patients cared in hospital.

The investigators propose here to evaluate insight in people presenting schizophrenia or related troubles, at the beginning of hospitalization (I1) and 1 month later (I2), to better characterize insight variations, and identify the sociodemographic, clinical and therapeutic variables linked to it.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 205
• Est. completion date: July 2017
• Est. primary completion date: July 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of schizophrenia,

• Persons requiring psychiatric care in one of the participating care unit

• I1 < 6 (absent or bad consciousness of the trouble).

Exclusion Criteria:

• I1=6

• Expression capacities incompatible with Q8 scale quotation (delirium, no understanding of the french language, mutism, contention or therapeutic isolation)

• Age under 18, absence of health care insurance

Related Conditions & MeSH terms

• Schizophrenia

Intervention

Other:
• insight variation measure
insight variation between the firt week of hospitalization and 1 month later

Locations

Country	Name	City	State
France	Centre Hospitalier Esquirol	Limoges
France	Centre Hospitalier La Vallette	Saint-Vaury

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Esquirol

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of collected data explaining insight variation between the first week of hospitalization (I1) and 1 month later (I2) in a model of logistic regression	identification of the variables explaining insight variation when it is = 1,5: social and demographic data : age, gender, marital status, study level clinical : disease duration, Positive and Negative Syndrome Scale (PANSS), type of trouble therapeutic : care and treatments received during hospitalization.	first month after hospitalization